Uncommon Mutations in NSCLC

Charu Aggarwal, MD, MPH, discusses treating patients with EGFR-mutant non­–small cell lung cancer.

Joshua K. Sabari, MD, discusses the importance of timely testing for uncommon mutations in non–small cell lung cancer.

Nicholas C. Rohs, MD, discusses databases of uncommon mutations in non–small cell lung cancer